Announcement by the Ministry of Health on the decisions of the Council of Ministers for the use of updated, adapted vaccines against COVID-19
, 15-09-2022
Announcement by the Ministry of Health regarding discontinuance of free COVID-19 rapid testing in August
, 12-08-2022
Announcement by the Ministry of Health on the decisions of the Council of Ministers
, 14-07-2022
Council of Ministers decides on reintroduction of masks indoors as of 8 July
, 06-07-2022
Announcement by the Ministry of Health on the decisions of the Council of Ministers
, 28-06-2022
Announcement by the Ministry of Health on the epidemiological situation in relation with COVID-19
, 24-06-2022
Changes to the operating hours of COVID-19 vaccination centres
, 30-05-2022
Clarifications by the Ministry of Health on the decisions of the Council of Ministers which enter into force as of 1 June 2022
, 30-05-2022
Action Plan for the smooth operation of flights and the operation of airports and ports, to be abolished
, 27-05-2022
Announcement by the Ministry of Health on the decisions of the Council of Ministers - 27 May 2022
, 27-05-2022
Call centre for the management of COVID-19 cases and contacts, launched by the Ministry of Health
, 19-05-2022
Changes to the operating hours of the Vaccination Centres against COVID-19
, 18-05-2022
Announcement of the Ministry of Health on the obligation to use a mask indoors
, 16-05-2022
Announcement of the Ministry of Health on the decisions of the Council of Ministers which enter into force as of 15 May 2022
, 13-05-2022
Availability of Paxlovid for prescription to patients with mild/moderate COVID-19 disease
, 11-05-2022
Announcement by the Ministry of Health on the administration of a booster/4th dose to vulnerable groups of the population
, 10-05-2022
Statement by the Minister of Health regarding the decisions of the Council of Ministers for further relaxations on the restrictive measures against COVID-19
, 10-05-2022
Administration of a booster/4th dose to persons over 60 years of age
, 22-04-2022
Readjustment plan on restrictions against COVID-19, as of 22 April 2022
, 22-04-2022
Setting of a maximum price limit on COVID-19 self-test package
, 21-04-2022
Issuance of the vaccination and recovery EUDCC European Digital Certificate for Turkish Cypriots
, 20-04-2022
Statement by the Minister of Health regarding the decisions of the Council of Ministers
, 20-04-2022
Administration of a booster/4th dose through appointment or through walk-in vaccination centres
, 19-04-2022
Readjustment Plan on Restrictions against COVID-19, as of 18 April 2022
, 19-04-2022
New Action Plan for smooth operation of flights and operation of airports enters into force as of 18 April
, 18-04-2022
As of 18 April 2022, Cyprus abolishes FlightPass, country categorization and most travel-related protocols
, 14-04-2022
Operating hours and places of vaccination centres for the administration of the booster/4th dose of the vaccine to persons of 70 years and over
, 12-04-2022
Extension of the platform for the issuance of an EUDCC European Digital Certificate for gradual coverage of Turkish Cypriots based on age criteria
, 11-04-2022
Announcement by the Ministry of Health on the administration of the booster/4th dose of the vaccine to persons aged 70 years and over
, 11-04-2022
Epidemiological risk assessment of countries concerning COVID-19, dated 11/04/2022
, 11-04-2022
Clarifications on the decisions of the Council of Ministers regarding the relaxation of measures
, 11-04-2022
New Action Plan for the smooth operation of flights and the operation of airports, as of 18 April 2022
, 07-04-2022
Statement by the Minister of Health regarding the decisions of the Council of Ministers - relaxation of measures
, 07-04-2022
Epidemiological risk assessment of countries concerning COVID-19, dated 04/04/2022
, 04-04-2022
Announcement by the Ministry of Health on the administration of the booster vaccine dose against COVID-19
, 29-03-2022
Announcement of the Ministry of Health on the release of positive COVID-19 cases
, 28-03-2022
Epidemiological risk assessment of countries concerning COVID-19, dated 28/03/2022
, 28-03-2022
Announcement by the Ministry of Health regarding the 25th March parade
, 24-03-2022
Announcement by the Ministry of Health on the decisions of the Council of Ministers regarding COVID-19 vaccine boosters
, 22-03-2022
Epidemiological risk assessment of countries concerning COVID-19, dated 21/03/2022
, 21-03-2022
Decisions of the Council of Ministers on the new Covid-19 measures
, 16-03-2022
Recommendations of the National Vaccination Advisory Committee of the Ministry of Health
, 14-03-2022
Epidemiological risk assessment of countries concerning COVID-19, dated 14/03/2022
, 14-03-2022
Distribution of 3rd package of free COVID-19 self-tests continues
, 09-03-2022
Announcement by the Ministry of Health for the implementation of the “test to stay” measure in the Education Service
, 09-03-2022
Epidemiological risk assessment of countries concerning COVID-19, dated 07/03/2022
, 09-03-2022
Announcement by the Ministry Health on the release of close contacts who have not been isolated from a COVID-19 positive case
, 08-03-2022
Appointment availability for the Nuvaxovid vaccine via the vaccination portal
, 08-03-2022
Readjustment plan on restrictions against COVID-19
, 08-03-2022
Guidelines by the Ministry of Health for the release of positive COVID-19 cases
, 07-03-2022
Statement by the Minister of Health on the decisions of the Council of Ministers
, 03-03-2022
Readjustment plan regarding measures against COVID-19
, 03-03-2022
Operation of a Vaccination Centre in Larnaka Old Hospital as replacement of the Larnaka Port Vaccination Centre
, 25-02-2022
What changes in the check of the European Digital Covid Certificates (EUDCC) through the CovScanCyprus application
, 24-02-2022
Clarifications on a special protocol for catering and entertainment establishments
, 23-02-2022
Distribution of free of charge self-tests for COVID-19 in pharmacies
, 23-02-2022
Rapid Antigen Testing Units – 23 February 2022
, 22-02-2022
Rapid Antigen Testing Units – 22 February 2022
, 21-02-2022
As of 21 February 2022, the new Action Plan for the smooth operation of flights and the operation of airports enters into force
, 18-02-2022
Rapid Antigen Testing Units – 21 February 2022
, 18-02-2022
Rapid Antigen Testing Units – 20 February 2022
, 18-02-2022
Rapid Antigen Testing Units – 19 February 2022
, 18-02-2022
Changes to the operating hours of the Vaccination Centres as of Monday 21 February 2022
, 18-02-2022
Rapid Antigen Testing Units – 18 February 2022
, 17-02-2022
Reminder to beneficiaries on the distribution of self-test kits for COVID-19
, 16-02-2022
Clarifications about the lifting of the ban on entry to various venues by unvaccinated persons or persons who have not completed their vaccination
, 16-02-2022
Rapid Antigen Testing Units – 17 February 2022
, 16-02-2022
As of 21 February 2022, the new Action Plan for the smooth operation of flights and the operation of airports enters into force
, 15-02-2022
Statement by the Minister of Health on the decisions of the Council of Ministers
, 15-02-2022
Rapid Antigen Testing Units – 16 February 2022
, 15-02-2022
Rapid Antigen Testing Units – 15 February 2022
, 14-02-2022
Rapid Antigen Testing Units – 14 February 2022
, 11-02-2022
Rapid Antigen Testing Units – 13 February 2022
, 11-02-2022
Rapid Antigen Testing Units – 12 February 2022
, 11-02-2022
Rapid Antigen Testing Units – 11 February 2022
, 10-02-2022
Rapid Antigen Testing Units – 10 February 2022
, 09-02-2022
Rapid Antigen Testing Units – 9 February 2022
, 08-02-2022
COVID-19 vaccination portal software upgraded
, 07-02-2022
European COVID-19 Digital Certificate including booster dose for Turkish Cypriots
, 07-02-2022
Rapid Antigen Testing Units – 8 February 2022
, 07-02-2022
Rapid Antigen Testing Units – 7 February 2022
, 05-02-2022
Rapid Antigen Testing Units – 6 February 2022
, 04-02-2022
Rapid Antigen Testing Units – 5 February 2022
, 04-02-2022
Change of operating hours of the vaccination centres against COVID-19 as of 7 February 2022
, 03-02-2022
Rapid Antigen Testing Units – 4 February 2022
, 03-02-2022
Announcement by the Ministry of Health regarding the decisions of the Council of Ministers
, 02-02-2022
Rapid Antigen Testing Units – 3 February 2022
, 02-02-2022
Clarifications by the Ministry of Health on the procedure for implementing the measure “test to stay” in primary and secondary education
, 01-02-2022
Rapid Antigen Testing Units – 2 February 2022
, 01-02-2022
Rapid Antigen Testing Units – 1 February 2022
, 31-01-2022
Start of a review concerning the conduct of studies at Synchron Research Services, India
, 31-01-2022
Rapid Antigen Testing Units – 31 January 2022
, 28-01-2022
Rapid Antigen Testing Units – 29 January 2022
, 28-01-2022
Rapid Antigen Testing Units – 28 January 2022
, 28-01-2022
Frequently Asked Questions - CovScan
, 27-01-2022
Reminder regarding the use of the CovScan Cyprus application
, 27-01-2022
Vaccinations of children aged 5-11 in cooperation with the Paediatric Society of Cyprus
, 26-01-2022
Announcement by the Ministry of Health regarding the decisions of the Council of Ministers
, 26-01-2022
Rapid Antigen Testing Units – 27 January 2022
, 26-01-2022
Rapid Antigen Testing Units – 26 January 2022
, 25-01-2022
Announcement by the Ministry of Health regarding changes to ‘test-to-stay’ measure in schools – testing units at schools
, 24-01-2022
Rapid Antigen Testing Units – 25 January 2022
, 24-01-2022
Reduction of close contacts’ self-isolation period as of 24 January 2022
, 22-01-2022
Rapid Antigen Testing Units – 24 January 2022
, 22-01-2022
Rapid Antigen Testing Units – 23 January 2022
, 22-01-2022
Rapid Antigen Testing Units – 22 January 2022
, 22-01-2022
Answers to citizens’ enquiries about the process of entering data on Phase platform
, 21-01-2022
Clarifications regarding the EUDCC Recovery Certificate following the announcements of the Council of Ministers of 21 December 2021
, 20-01-2022
Distribution of free of charge self-tests for COVID-19 continues in pharmacies
, 20-01-2022
European COVID-19 Digital Certificate, including booster dose, for Turkish Cypriots
, 20-01-2022
The Council of Ministers approved the new Action Plan for the smooth operation of flights and the operation of airports
, 19-01-2022
European COVID-19 Digital Certificate including booster dose
, 19-01-2022
Rapid Antigen Testing Units – 20 January 2022
, 19-01-2022
The use of EUDCC certificates is temporarily revoked for persons who have tested positive to COVID-19
, 19-01-2022
latest safety data provide reassurance about use of mRNA vaccines during pregnancy
, 19-01-2022
Announcement by the Ministry of Health for the Vaccination Plan against COVID-19
, 17-01-2022
Rapid Antigen Testing Units – 19 January 2022
, 17-01-2022
Rapid Antigen Testing Units – 18 January 2022
, 17-01-2022
Rapid Antigen Testing Units – 17 January 2022
, 14-01-2022
Rapid Antigen Testing Units – 16 January 2022
, 14-01-2022
Rapid Antigen Testing Units – 15 January 2022
, 14-01-2022
Changes to the Release Protocol and introduction of an automated release procedure
, 14-01-2022
Rapid antigen testing units - 14 January 2022
, 14-01-2022
Rapid antigen testing units – 13 January 2022
, 13-01-2022
Announcement by the Minister of Health, Mr Michalis Hadjipantela, on the decisions of the Council of Ministers
, 12-01-2022
Option for a 24-hour rapid test for passengers travelling to the Republic of Cyprus
, 12-01-2022
Rapid antigen testing units – 12 January 2022
, 12-01-2022
Rapid antigen testing units – 11 January 2022
, 10-01-2022
Updated instructions for management of COVID-19 cases and their close contacts
, 10-01-2022
Rapid antigen testing units – 10 January 2022
, 10-01-2022
Rapid antigen testing units – 9 January 2022
, 09-01-2022
Rapid antigen testing units – 8 January 2022
, 08-01-2022
Rapid antigen testing units – 7 January 2022
, 07-01-2022
Clarifications on the decisions of the Council of Ministers — 5 January 2022
, 06-01-2022
Statement by the Minister of Health, Mr Michalis Hadjipantela, on the decisions of the Council of Ministers
, 05-01-2022
Rapid antigen testing units – 6 January 2022
, 05-01-2022
Rapid antigen testing units – 5 January 2022
, 04-01-2022
Revised operating hours of Ammochostos Vaccination Centre — Change of self-test availability hours at Lemesos Maternity Centre
, 04-01-2022
Rapid antigen testing units – 4 January 2022
, 04-01-2022
Rapid antigen testing units – 3 January 2022
, 03-01-2022
Rapid antigen testing units – 2 January 2022
, 02-01-2022
Rapid antigen testing units – 1 January 2022
, 01-01-2022
Epidemiological risk assessment of countries concerning COVID-19, dated 31/12/2021
, 31-12-2021
Clarifications on the decisions of the Council of Ministers for containing the spread of COVID-19
, 31-12-2021
Statement by the Minister of Health, Mr Michalis Hadjipantela, on the decisions of the Council of Ministers
, 29-12-2021
Rapid antigen testing units – 30 December 2021
, 29-12-2021
Rapid antigen testing units – 29 December 2021
, 29-12-2021
Vaccinations of children aged 5-11 years in cooperation with the Cyprus Paediatric Society
, 28-12-2021
Free of charge self-tests for Cypriot citizen beneficiaries or residents of Cyprus who are not registered in the GHS
, 28-12-2021
Citizens may update the COVID-19 Positive Cases Data Entry Platform
, 28-12-2021
Rapid antigen testing units – 28 December 2021
, 28-12-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 27/12/2021
, 27-12-2021
Rapid antigen testing units – 27 December 2021
, 26-12-2021
Rapid antigen testing units – 23 December 2021
, 23-12-2021
Clarifications on the decisions of the Council of Ministers for containing the spread of COVID-19
, 22-12-2021
Administration of the 3rd/booster dose available to students at all walk-in centres on 27 and 28 December
, 22-12-2021
Rapid antigen testing units – 22 December 2021
, 22-12-2021
Statement by the Minister of Health following a meeting of the Council of Ministers – Decisions on new measures
, 21-12-2021
Rapid antigen testing units – 21 December 2021
, 21-12-2021
Free COVID-19 self-tests for citizens, as of 21 December
, 20-12-2021
Temporary operation of Latsia Vaccination Centre only for scheduled appointments
, 20-12-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 20/12/2021
, 20-12-2021
Rapid antigen testing units – 20 December 2021
, 20-12-2021
Rapid antigen testing units – 19 December 2021
, 19-12-2021
Announcement by the Ministry of Health for passengers entering the Republic of Cyprus from the United Kingdom as of 18 December
, 18-12-2021
Rapid antigen testing units – 18 December 2021
, 18-12-2021
What changes regarding the checks of European Digital COVID Certificate (EUDCC) through the application CovScan Cyprus
, 17-12-2021
Rapid antigen testing units – 17 December 2021
, 17-12-2021
Rapid antigen testing units – 16 December 2021
, 16-12-2021
Automated check of citizens through the CovScan Cyprus application, as of 18 December
, 15-12-2021
Rapid antigen testing units – 15 December 2021
, 15-12-2021
Interval before COVID-19 booster shot reduced to five months and two weeks
, 14-12-2021
Clarifications on the decisions of the Council of Ministers — 13 December 2021
, 13-12-2021
Statement by the Minister of Health on the decisions of the Council of Ministers regarding the pandemic
, 13-12-2021
Rapid antigen testing units – 14 December 2021
, 13-12-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 13/12/2021
, 13-12-2021
Rapid antigen testing units – 13 December 2021
, 13-12-2021
Self-tests will be available in pharmacies free of charge as of 20 December
, 12-12-2021
Rapid antigen testing units – 12 December 2021
, 12-12-2021
The Vaccination Portal is available for vaccination appointments with the 2nd dose of the Johnson & Johnson vaccine
, 10-12-2021
Rapid antigen testing units – 11 December 2021
, 10-12-2021
EMA and ECDC recommendations on heterologous vaccination courses against COVID-19
, 10-12-2021
Rapid antigen testing units – 10 December 2021
, 10-12-2021
Rapid antigen testing units – 9 December 2021
, 08-12-2021
Administration of the booster/3rd dose of the vaccine against COVID-19 for individuals aged 18 and over
, 07-12-2021
Rapid antigen testing units – 8 December 2021
, 07-12-2021
EMA recommends approval for use of RoActemra in adults with severe COVID-19
, 07-12-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 06/12/2021
, 06-12-2021
Rapid antigen testing units – 6 December 2021
, 06-12-2021
Rapid antigen testing units – 5 December 2021
, 04-12-2021
Rapid antigen testing units – 4 December 2021
, 03-12-2021
Rapid antigen testing units – 3 December 2021
, 03-12-2021
Statement by the Minister of Health, Mr Michalis Hadjipantela, following a meeting of the Council of Ministers – Decisions on new measures
, 02-12-2021
Passengers aged 12 years and over are obliged to carry out a PCR test upon arrival in Cyprus
, 02-12-2021
Rapid antigen testing units – 2 December 2021
, 02-12-2021
Rapid antigen testing units – 1 December 2021
, 01-12-2021
Rapid antigen testing units – 30 November 2021
, 30-11-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 29/11/2021
, 29-11-2021
Administration of the booster/3rd dose of the vaccine against COVID-19 for individuals aged 30 and over
, 29-11-2021
Rapid antigen testing units – 29 November 2021
, 29-11-2021
Rapid antigen testing units – 28 November 2021
, 28-11-2021
Rapid antigen testing units – 27 November 2021
, 27-11-2021
Clarifications by the Ministry of Health on the new measures to contain the pandemic
, 26-11-2021
Entry to the Republic restricted due to new SARS-COV-2 virus strain
, 26-11-2021
Rapid antigen testing units – 26 November 2021
, 25-11-2021
Statement by the Minister of Health, Mr Michalis Hadjipantela, on the decisions of the Council of Ministers on measures to contain the pandemic
, 24-11-2021
Rapid antigen testing units – 24 November 2021
, 23-11-2021
EMA evaluating data on booster dose of COVID-19 Vaccine Janssen
, 23-11-2021
Rapid antigen testing units – 23 November 2021
, 23-11-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 22/11/2021
, 22-11-2021
EMA starts review of Paxlovid for treating patients with COVID-19
, 22-11-2021
EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19
, 22-11-2021
Rapid antigen testing units – 22 November 2021
, 22-11-2021
Rapid antigen testing units – 20 November 2021
, 20-11-2021
EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with COVID-19
, 19-11-2021
Rapid antigen testing units – 19 November 2021
, 19-11-2021
Extension of working hours at walk-in vaccination centres
, 19-11-2021
Rapid antigen testing units – 18 November 2021
, 18-11-2021
SafePass possession checks via the CovScan application will be mandatory as of 22 November
, 17-11-2021
EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine, Nuvaxovid
, 17-11-2021
Rapid antigen testing units – 17 November 2021
, 17-11-2021
Administration of a booster dose for individuals aged 40 years and over, begins
, 16-11-2021
Walk-in vaccination centre to operate at Europe Square in Larnaka, on Saturday, 20 November
, 16-11-2021
Rapid antigen testing units – 16 November 2021
, 16-11-2021
Council of Ministers: Administration of a booster dose of a COVID-19 vaccine for the population aged 18 years and over
, 15-11-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 15/11/2021
, 15-11-2021
Rapid antigen testing units – 15 November 2021
, 15-11-2021
Rapid antigen testing units – 14 November 2021
, 14-11-2021
Rapid antigen testing units – 13 November 2021
, 13-11-2021
COVID-19: EMA recommends authorisation of two monoclonal antibody medicines
, 12-11-2021
Rapid antigen testing units – 12 November 2021
, 12-11-2021
Rapid antigen testing units – 11 November 2021
, 11-11-2021
Special leave of absence granted to employees who are vaccinated with a booster dose of the COVID-19 vaccine
, 10-11-2021
EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to 11
, 10-11-2021
COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir
, 10-11-2021
Rapid antigen testing units – 10 November 2021
, 10-11-2021
Rapid antigen testing units – 9 November 2021
, 09-11-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 08/11/2021
, 08-11-2021
Rapid antigen testing units – 8 November 2021
, 08-11-2021
Rapid antigen testing units – 7 November 2021
, 07-11-2021
Rapid antigen testing units – 6 November 2021
, 06-11-2021
Booster dose administration procedure for people who were vaccinated with Johnson&Johnson vaccine, for diabetics and for people aged 50 and over
, 05-11-2021
Rapid antigen testing units – 5 November 2021
, 05-11-2021
SafePass possession checks via the CovScan application will be optional until 22 November
, 05-11-2021
Extension of measures against the spread of COVID-19 — A booster dose available for people over 50 and for individuals with severe obesity
, 04-11-2021
Questions and answers on end of rolling review for antibodies bamlanivimab and etesevimab for COVID-19
, 04-11-2021
EMA ends rolling review of the antibodies bamlanivimab and etesevimab for COVID-19 following withdrawal by Lilly
, 04-11-2021
Rapid antigen testing units – 4 November 2021
, 04-11-2021
Rapid antigen testing units – 3 November 2021
, 03-11-2021
Home administration of a booster dose of the vaccine against COVID-19 to bedridden patients
, 02-11-2021
Rapid antigen testing units – 2 November 2021
, 02-11-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 01/11/2021
, 01-11-2021
Rapid antigen testing units – 1 November 2021
, 01-11-2021
Rapid antigen testing units – 31 October 2021
, 31-10-2021
Rapid antigen testing units – 30 October 2021
, 30-10-2021
Announcement of the Deputy Ministry of Research, Innovation and Digital Policy for the issuance of a European Digital COVID Certificate to Turkish Cypriots
, 29-10-2021
Rapid antigen testing units – 29 October 2021
, 29-10-2021
Rapid antigen testing units – 28 October 2021
, 28-10-2021
Extension of measures against the spread of COVID-19 — A booster dose available for individuals vaccinated with J&J
, 27-10-2021
Rapid antigen testing units – 27 October 2021
, 27-10-2021
COVID-19: EMA starts rolling review of molnupiravir
, 26-10-2021
Spikevax: EMA recommendation on booster dose
, 26-10-2021
Rapid antigen testing units – 26 October 2021
, 26-10-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 25/10/2021
, 25-10-2021
Rapid antigen testing units – 25 October 2021
, 25-10-2021
Rapid antigen testing units – 24 October 2021
, 24-10-2021
Rapid antigen testing units – 23 October 2021
, 23-10-2021
Rapid antigen testing units – 22 October 2021
, 22-10-2021
Rapid antigen testing units – 21 October 2021
, 21-10-2021
Rapid antigen testing units – 20 October 2021
, 20-10-2021
Rapid antigen testing units – 19 October 2021
, 19-10-2021
Management of COVID-19 cases and their close contacts
, 19-10-2021
Vaccinations with the 3rd dose begin for people aged 60 years and over
, 18-10-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 18/10/2021
, 18-10-2021
Rapid antigen testing units – 18 October 2021
, 18-10-2021
Rapid antigen testing units – 17 October 2021
, 17-10-2021
Rapid antigen testing units – 16 October 2021
, 16-10-2021
Council of Ministers: The age limit for the administration of the booster/3rd dose is reduced to 60 and new vulnerable groups are added
, 15-10-2021
Rapid antigen testing units – 15 October 2021
, 15-10-2021
Rapid antigen testing units – 14 October 2021
, 14-10-2021
EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG
, 13-10-2021
Vaccination portal reopens as of 15 October for arrangement of vaccination appointments with 1st and 3rd doses
, 13-10-2021
Rapid antigen testing units – 13 October 2021
, 13-10-2021
Ministry of Health proceeds with the administration of the 3rd dose of COVID-19 vaccine to persons 65 years of age and older
, 12-10-2021
EMA receives application for marketing authorisation for ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19
, 12-10-2021
Rapid antigen testing units – 12 October 2021
, 12-10-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 11/10/2021
, 11-10-2021
Rapid antigen testing units – 11 October 2021
, 11-10-2021
Rapid antigen testing units – 10 October 2021
, 10-10-2021
Rapid antigen testing units – 9 October 2021
, 09-10-2021
Decisions of the Council of Ministers on restrictive measures against the spread of COVID-19
, 08-10-2021
Rapid antigen testing units – 8 October 2021
, 08-10-2021
Large walk-in center for citizens’ vaccination to operate in Lemesos on 10 October
, 07-10-2021
Vaccination Portal at the disposal of people aged 70 years and over as of 8 October
, 07-10-2021
Rapid antigen testing units – 7 October 2021
, 07-10-2021
Rapid antigen testing units – 6 October 2021
, 06-10-2021
SafePass will be issued only for fully vaccinated individuals as of October 18
, 05-10-2021
Vaccination proceeds with the administration of a 3rd dose to individuals aged 75 and over
, 05-10-2021
Rapid antigen testing units – 5 October 2021
, 05-10-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 4/10/2021
, 04-10-2021
Comirnaty and Spikevax: EMA recommendations on extra doses and boosters
, 04-10-2021
Rapid antigen testing units – 4 October 2021
, 04-10-2021
Rapid antigen testing units – 3 October 2021
, 03-10-2021
Vaccination Portal opens for 3rd dose vaccination appointments
, 02-10-2021
Rapid antigen testing units – 2 October 2021
, 02-10-2021
Rapid antigen testing units – 1 October 2021
, 01-10-2021
Rapid antigen testing units – 30 September 2021
, 30-09-2021
Rapid antigen testing units – 29 September 2021
, 29-09-2021
Announcement of the Deputy Ministry of Research on the issuance of a European Digital COVID Certificate to Turkish Cypriots
, 28-09-2021
Rapid antigen testing units – 28 September 2021
, 28-09-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 27/09/2021
, 27-09-2021
Rapid antigen testing units – 27 September 2021
, 27-09-2021
Rapid antigen testing units – 26 September 2021
, 26-09-2021
Rapid antigen testing units – 25 September 2021
, 25-09-2021
Rapid antigen testing units – 24 September 2021
, 24-09-2021
Vaccination with the 3rd dose for citizens aged 83 and over
, 23-09-2021
Rapid antigen testing units – 23 September 2021
, 23-09-2021
Rapid antigen testing units – 22 September 2021
, 22-09-2021
Gradual vaccination with 3rd dose for individuals aged 65 and over to begin at walk-in vaccination centres
, 21-09-2021
Rapid antigen testing units – 21 September 2021
, 21-09-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 20/09/2021
, 20-09-2021
Rapid antigen testing units – 20 September 2021
, 20-09-2021
Rapid antigen testing units – 19 September 2021
, 19-09-2021
Rapid antigen testing units – 18 September 2021
, 18-09-2021
Rapid antigen testing units – 17 September 2021
, 17-09-2021
Announcement of the Deputy Ministry of Research, Innovation and Digital Policy on the issuance of a European Digital COVID Certificate to Turkish Cypriots
, 16-09-2021
Rapid antigen testing units – 16 September 2021
, 16-09-2021
Efforts to promote COVID-19 vaccination are intensifying
, 15-09-2021
Rapid antigen testing units – 15 September 2021
, 15-09-2021
Rapid antigen testing units – 14 September 2021
, 14-09-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 13/09/2021
, 13-09-2021
Rapid antigen testing units – 13 September 2021
, 13-09-2021
Rapid antigen testing units – 12 September 2021
, 12-09-2021
Rapid antigen testing units – 11 September 2021
, 11-09-2021
Rapid antigen testing units – 10 September 2021
, 10-09-2021
Vaccination Centres re-open every Saturday for the best service of school and university students
, 09-09-2021
Rapid antigen testing units – 9 September 2021
, 09-09-2021
Rapid antigen testing units – 8 September 2021
, 08-09-2021
Rapid antigen testing units – 7 September 2021
, 07-09-2021
Vaccination procedure with 3rd dose for specific groups of the population
, 06-09-2021
EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty
, 06-09-2021
New school year begins with mobile testing units in Secondary Education
, 06-09-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 06/09/2021
, 06-09-2021
Rapid antigen testing units – 6 September 2021
, 06-09-2021
Rapid antigen testing units – 5 September 2021
, 05-09-2021
Rapid antigen testing units – 4 September 2021
, 04-09-2021
Rapid antigen testing units – 3 September 2021
, 03-09-2021
ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines
, 02-09-2021
Rapid antigen testing units – 2 September 2021
, 02-09-2021
Rapid antigen testing units – 1 September 2021
, 01-09-2021
CovScan Cyprus application at the service of citizens and businesses
, 31-08-2021
Rapid antigen testing units – 31 August 2021
, 31-08-2021
Announcement by the Deputy Ministry of Research on the issuance of the EU Digital COVID Certificate to Turkish Cypriots
, 30-08-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 30/8/2021
, 30-08-2021
Rapid antigen testing units – 30 August 2021
, 30-08-2021
Rapid antigen testing units – 29 August 2021
, 29-08-2021
Rapid antigen testing units – 28 August 2021
, 28-08-2021
Rapid antigen testing units – 27 August 2021
, 27-08-2021
Rapid antigen testing units – 26 August 2021
, 26-08-2021
Rapid antigen testing units – 25 August 2021
, 25-08-2021
Rapid antigen testing units – 24 August 2021
, 24-08-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 23/8/2021
, 23-08-2021
Rapid antigen testing units – 23 August 2021
, 23-08-2021
Rapid antigen testing units – 22 August 2021
, 22-08-2021
Rapid antigen testing units – 21 August 2021
, 21-08-2021
Rapid antigen testing units – 20 August 2021
, 20-08-2021
Rapid antigen testing units – 19 August 2021
, 19-08-2021
Rapid antigen testing units – 18 August 2021
, 18-08-2021
Announcement by the Deputy Ministry of Research, Innovation and Digital Policy for the issuance of the EU Digital COVID Certificate to Turkish Cypriots
, 17-08-2021
Rapid antigen testing units – 17 August 2021
, 17-08-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 16/8/2021
, 16-08-2021
Rapid antigen testing units – 16 August 2021
, 16-08-2021
Rapid antigen testing units – 14 August 2021
, 14-08-2021
Clarifications regarding free rapid antigen tests for pregnant women who are not recommended for vaccination for medical reasons
, 13-08-2021
Request for Issuance of a Certificate of approval for free rapid antigen tests for COVID-19
, 13-08-2021
Rapid antigen testing units – 13 August 2021
, 13-08-2021
EUDCC – EU Digital Certificate format required for all passengers as of 13 August
, 12-08-2021
Rapid antigen testing units – 12 August 2021
, 12-08-2021
Rapid antigen testing units – 11 August 2021
, 11-08-2021
Rapid antigen testing units – 10 August 2021
, 10-08-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 9/8/2021
, 09-08-2021
Rapid antigen testing units – 9 August 2021
, 09-08-2021
Rapid antigen testing units – 8 August 2021
, 08-08-2021
Rapid antigen testing units – 7 August 2021
, 07-08-2021
Rapid antigen testing units – 6 August 2021
, 06-08-2021
Rapid antigen testing units – 5 August 2021
, 05-08-2021
Full vaccination is key to protecting against serious COVID-19, EMA and ECDC say
, 05-08-2021
Guidelines by the Minister of Transport regarding means of Public Transport
, 04-08-2021
Revised guidelines for the discharge of positive cases without symptoms or with mild symptoms
, 04-08-2021
Rapid antigen testing units – 4 August 2021
, 04-08-2021
Vaccination of non-registered citizens or beneficiaries of the General Healthcare System through the “walk-in” centres
, 03-08-2021
Reminder of the procedure for the approval of requests for free rapid antigen tests, by way exception, for medical reasons
, 03-08-2021
Rapid antigen testing units – 3 August 2021
, 03-08-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 2/8/2021
, 02-08-2021
Rapid antigen testing units – 2 August 2021
, 02-08-2021
Rapid antigen testing units – 1 August 2021
, 01-08-2021
Reminder regarding the population groups that can perform rapid tests through the testing units of the Ministry of Health
, 31-07-2021
Rapid antigen testing units – 31 July 2021
, 31-07-2021
Answers to Frequently Asked Questions on the decisions of the Council of Ministers
, 30-07-2021
Vaccination procedure for minors aged 12 to 17
, 30-07-2021
Procedure for issuing a certificate by way of exception, allowing for a free rapid antigen test to a person who cannot be vaccinated for medical reasons
, 30-07-2021
Statement by the Minister of Health, Mr Michalis Hadjipantela, on the Council of Ministers’ decisions
, 30-07-2021
Rapid antigen testing units – 30 July 2021
, 30-07-2021
Rapid antigen testing units – 29 July 2021
, 29-07-2021
Rapid antigen testing units – 28 July 2021
, 28-07-2021
Issuance of EU Digital COVID Certificate and SafePass to individuals who have been vaccinated or have tested positive for covid in countries outside the EU, EEA or Switzerland
, 27-07-2021
Rapid antigen testing units – 27 July 2021
, 27-07-2021
Change of the criteria regarding the conduct of a PCR laboratory test for COVID–19 upon arrival at the airports
, 26-07-2021
Answers to frequently asked questions about rapid antigen tests as of 1st of August
, 26-07-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 26/07/2021
, 26-07-2021
Rapid antigen testing units – 26 July 2021
, 26-07-2021
Rapid antigen testing units – 25 July 2021
, 25-07-2021
Rapid antigen testing units – 24 July 2021
, 24-07-2021
Rapid antigen testing units – 23 July 2021
, 23-07-2021
COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect
, 23-07-2021
Scheduling of appointments for vaccination against COVID-19 through the telephone lines of the Ministry of Health
, 22-07-2021
Rapid antigen testing units – 22 July 2021
, 22-07-2021
Issuance of the EU Digital COVID Certificate for individuals who have been vaccinated or have tested positive for the virus in countries outside the EU, EEA or Switzerland
, 21-07-2021
Rapid antigen testing units – 21 July 2021
, 21-07-2021
Administration of 2nd dose of covid vaccine in Cyprus to individuals who have been vaccinated with 1st dose abroad
, 20-07-2021
Rapid antigen testing units – 20 July 2021
, 20-07-2021
Guidelines by the Minister of Transport for persons employed in means of Public Transport and for passengers
, 19-07-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 19/07/2021
, 19-07-2021
Rapid antigen testing units – 19 July 2021
, 19-07-2021
Rapid antigen testing units – 18 July 2021
, 18-07-2021
Operation of hotlines for the rescheduling of appointments for the administration of the 2nd dose
, 17-07-2021
Rapid antigen testing units – 17 July 2021
, 17-07-2021
Incentives provided to young people by companies and organisations to promote vaccinations
, 16-07-2021
Statements by the Commissioner for the Citizen on the incentives to increase vaccination coverage
, 16-07-2021
Answers to frequently asked questions about the decisions of the Council of Ministers, dated 16 July 2021
, 16-07-2021
Statement by the Minister of Health, Mr Michalis Hadjipantela, on the Council of Ministers’ decisions for containing the pandemic
, 16-07-2021
Address by the President of the Republic, Mr Nicos Anastasiades
, 16-07-2021
Rapid antigen testing units – 16 July 2021
, 16-07-2021
Rapid antigen testing units – 15 July 2021
, 15-07-2021
Access of citizens to vaccination is facilitated through "walk-in" vaccination centres
, 14-07-2021
Rapid antigen testing units – 14 July 2021
, 14-07-2021
Answers to frequently asked questions about the vaccines against COVID-19 by the Pharmaceutical Services of the Ministry of Health
, 13-07-2021
Rapid antigen testing units – 13 July 2021
, 13-07-2021
Answers to questions relating to the implementation and monitoring of the measures of the Quarantine Law Decree (No. 28), by the Data Protection Commissioner
, 12-07-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 12/7/2021
, 12-07-2021
Rapid antigen testing units – 12 July 2021
, 12-07-2021
Rapid antigen testing units – 11 July 2021
, 11-07-2021
Rapid antigen testing units – 10 July 2021
, 10-07-2021
Vaccination procedure for persons aged 16 and 17 years
, 09-07-2021
Reassessment of the measure for the operation of theatres, amphitheatres, cinemas and other performance halls from 13 July
, 09-07-2021
Management of COVID-19 cases and their close contacts
, 09-07-2021
EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome
, 09-07-2021
Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis
, 09-07-2021
Rapid antigen testing units – 9 July 2021
, 09-07-2021
Rapid antigen testing units – 8 July 2021
, 08-07-2021
Statement by the Minister of Health, Mr Michalis Hadjipantelas, on the decisions of the Council of Ministers
, 07-07-2021
Rapid antigen testing units – 7 July 2021
, 07-07-2021
Rapid antigen testing units – 6 July 2021
, 06-07-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 5/7/2021
, 05-07-2021
Rapid antigen testing units – 5 July 2021
, 05-07-2021
Rapid antigen testing units – 4 July 2021
, 04-07-2021
Clarifications on the decisions of the Council of Ministers - July 2, 2021
, 03-07-2021
Rapid antigen testing units – 3 July 2021
, 03-07-2021
Statement by the Minister of Health, Mr Michalis Hadjipantelas, on the decisions of the Council of Ministers for reinforcing vaccination coverage
, 02-07-2021
Rapid antigen testing units – 2 July 2021
, 02-07-2021
The Ministry of Health proceeds with vaccination of 16 and 17 year olds who are not registered in GeSY
, 01-07-2021
Written Consent Document of Parents / Legal Guardians for Vaccination of Minors against COVID-19
, 01-07-2021
Effort to increase vaccination coverage continues – The target for the vaccination of 65% of the population with the 1st dose has been achieved
, 01-07-2021
Rapid antigen testing units – 1 July 2021
, 01-07-2021
Presentation of the European Digital COVID Certificate
, 30-06-2021
Rapid antigen testing units – 30 June 2021
, 30-06-2021
Rapid antigen testing units – 29 June 2021
, 29-06-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 28/06/2021
, 28-06-2021
The Ministry of Health proceeds with the vaccination of individuals aged 16 and 17
, 28-06-2021
Rapid antigen testing units – 28 June 2021
, 28-06-2021
Rapid antigen testing units – 27 June 2021
, 27-06-2021
Concern over low vaccination rate among young people - A possible setback would have catastrophic consequences
, 26-06-2021
Rapid antigen testing units – 26 June 2021
, 26-06-2021
Rapid antigen testing units – 25 June 2021
, 25-06-2021
Results of strain sequencing tests show an increased presence of the Indian strain in the community
, 24-06-2021
Digital COVID Certificate for travelling to Cyprus accepted as of 1st July 2021
, 24-06-2021
Rapid antigen testing units – 24 June 2021
, 24-06-2021
Rapid antigen testing units – 23 June 2021
, 23-06-2021
Rapid antigen testing units – 22 June 2021
, 22-06-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 21/06/2021
, 21-06-2021
Rapid antigen testing units – 20 June 2021
, 20-06-2021
Rapid antigen testing units – 19 June 2021
, 19-06-2021
Minister of Health: We will fight health crisis through vaccination and personal protection measures
, 18-06-2021
Rapid antigen testing units – 18 June 2021
, 18-06-2021
Rapid antigen testing units – 17 June 2021
, 17-06-2021
Council of Ministers decides new easing of measures: presence of fans at games at 50% capacity and 10 persons per table in catering establishments
, 16-06-2021
Rapid antigen testing units – 16 June 2021
, 16-06-2021
Measures implemented at the points of entry of the Republic of Cyprus in order to contain the entry of SARS-CoV-2 mutations
, 15-06-2021
Rapid antigen testing units – 15 June 2021
, 15-06-2021
The pandemic will be treated effectively only through vaccination – Appointments available for all people over the age of 18
, 14-06-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 14/06/2021
, 14-06-2021
Rapid antigen testing units – 14 June 2021
, 14-06-2021
Rapid antigen testing units – 12 June 2021
, 12-06-2021
Vaxzevria COVID Vaccine – EMA advises against use in people with history of capillary leak syndrome
, 11-06-2021
COVID-19 vaccines: Update on ongoing evaluation of myocarditis and pericarditis
, 11-06-2021
Rapid antigen testing units – 11 June 2021
, 11-06-2021
Vaccination is our main weapon to exit the health crisis
, 10-06-2021
Revised list of clinical laboratories conducting rapid antigen tests that meet the specifications of the Ministry of Health
, 10-06-2021
Rapid antigen testing units – 10 June 2021
, 10-06-2021
Strategic restarting of the economy and of social activity – What changes as of 10 June 2021
, 09-06-2021
Rapid antigen testing units – 9 June 2021
, 09-06-2021
Rapid antigen testing units – 8 June 2021
, 08-06-2021
Issuance of SARS-CoV-2 Vaccination Certificate
, 07-06-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 07/06/2021
, 07-06-2021
EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome
, 07-06-2021
Rapid antigen testing units – 7 June 2021
, 07-06-2021
Rapid antigen testing units – 6 June 2021
, 06-06-2021
Rapid antigen testing units – 5 June 2021
, 05-06-2021
Wedding reception halls’ opening hours extended until 3am
, 04-06-2021
Rapid antigen testing units – 4 June 2021
, 04-06-2021
Rescheduling of vaccination appointments for 7 June, due to PASYNOs strike
, 04-06-2021
Announcement of the Ministry of Interior regarding the re-opening of checkpoints as of 4 June 2021
, 03-06-2021
Over 54% of the population has received the 1st dose of the vaccine – Schedule for the Vaccination Portal for the period 4-12 June
, 03-06-2021
SafePass is mandatory in indoor spaces
, 03-06-2021
Rapid antigen testing units – 3 June 2021
, 03-06-2021
Rapid antigen testing units – 2 June 2021
, 02-06-2021
Rapid antigen testing units – 1 June 2021
, 01-06-2021
Strategic restarting of the economy and of social activity – What changes as of 1 June 2021
, 31-05-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 31/05/2021
, 31-05-2021
Rapid antigen testing units – 31 May 2021
, 31-05-2021
Rapid antigen testing units – 29 May 2021
, 29-05-2021
Getting closer to the target for vaccination of 65% of the population with at least the first dose – Information on vaccination appointments
, 29-05-2021
First COVID-19 vaccine approved for children aged 12 to 15 in EU
, 28-05-2021
Answers to frequently asked questions on what changes as of 29 May 2021
, 28-05-2021
Rapid antigen testing units – 28 May 2021
, 28-05-2021
Insufficient data on use of inhaled corticosteroids to treat COVID-19
, 27-05-2021
Statement by the Minister of Health Mr Constantinos Ioannou on the decisions of the Council of Ministers regarding the pandemic
, 27-05-2021
Rapid antigen testing units – 27 May 2021
, 27-05-2021
Announcement by the Ministry of Health on the recommendations of the Scientific Advisory Committee for the AstraZeneca vaccine
, 26-05-2021
Citizens gradually informed about AstraZeneca 2nd dose rescheduling
, 26-05-2021
Rapid antigen testing units – 26 May 2021
, 26-05-2021
Cyprus travel protocol for vaccinated travellers
, 25-05-2021
Rapid antigen testing units – 25 May 2021
, 25-05-2021
Epidemiological risk assessment of countries concerning COVID-19, Dated 24/05/2021
, 24-05-2021
Rapid antigen testing units – 24 May 2021
, 24-05-2021
Vaccination coverage increases, the population is being shielded against COVID-19
, 23-05-2021
Rapid antigen testing units – 23 May 2021
, 23-05-2021
Threshold of half a million vaccinations surpassed - Schedule of appointments for 24-29 May
, 22-05-2021
Rapid antigen testing units – 22 May 2021
, 22-05-2021
Vaxzevria COVID-19 Vaccine: Further advice on blood clots and low blood platelets
, 21-05-2021
EMA issues advice on use of sotrovimab (VIR-7831) for treating COVID-19
, 21-05-2021
Rapid antigen testing units – 21 May 2021
, 21-05-2021
Sinopharm vaccine (BBIBP COVID-19) in the category of vaccines accepted by the Republic of Cyprus
, 20-05-2021
Rapid antigen testing units – 20 May 2021
, 20-05-2021
Results of specialized tests for the sequencing of SARS-CoV-2 virus strains
, 19-05-2021
Rapid antigen testing units – 19 May 2021
, 19-05-2021
Minister of Health: Vaccination and compliance with the precautionary measures will lead to the lifting of more restrictions
, 18-05-2021
Rapid antigen testing for employees and the general population – Testing units 18 May 2021
, 18-05-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 18/05/2021
, 18-05-2021
Rapid antigen testing for employees and the general population – Testing units 17 May 2021
, 17-05-2021
Rapid antigen testing for employees and the general population – Testing units 16 May 2021
, 16-05-2021
Rapid antigen testing for employees and the general population – Testing units 15 May 2021
, 15-05-2021
Vaccinations are at a more advanced stage compared to the initial plan – The Vaccination Portal opens for ages 18-21
, 14-05-2021
Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions of the Council of Ministers
, 14-05-2021
What changes as of 17 May in the framework of the strategy for the gradual resumption of the economy and social activity
, 14-05-2021
Maximum number of 10 persons in homes and gatherings
, 14-05-2021
Rapid antigen testing for employees and the general population – Testing units 14 May 2021
, 14-05-2021
Clarifications on the SafePass recovery SMS for individuals who have been positive COVID-19 cases
, 13-05-2021
AstraZeneca vaccine can be administered to individuals aged 20 years and over by their Personal Doctors
, 13-05-2021
The vaccination plan now focuses on young people – Answers to basic questions
, 13-05-2021
Rapid antigen testing for employees and the general population – Testing units 13 May 2021
, 13-05-2021
Cyprus ranks 4th among EU member states in terms of administration of vaccine doses per 100 inhabitants
, 12-05-2021
Rapid antigen testing for employees and the general population – Testing units 12 May 2021
, 12-05-2021
Additional measures to allow experts to focus on COVID-19 activities
, 11-05-2021
Rapid antigen testing for employees and the general population – Testing units 11 May 2021
, 11-05-2021
The appointment process for the 20-29 age group proceeds at a faster pace – Vaccination coverage by District
, 10-05-2021
Reminder as to the places where a ‟SafePassˮ is required
, 10-05-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 10/05/2021
, 10-05-2021
Rapid antigen testing for employees and the general population – Testing units 10 May 2021
, 10-05-2021
Declaration form - positive case
, 10-05-2021
Vaccination Portal opens for people aged 29 and 30
, 09-05-2021
Rapid antigen testing for employees and the general population – Testing units 9 May 2021
, 09-05-2021
Implementation of the ‟SafePassˮ Decision as of 10 May
, 08-05-2021
Conditions applied to vaccinated passengers
, 08-05-2021
Rapid antigen testing for employees and the general population – Testing units 8 May 2021
, 08-05-2021
Schedule for the arrangement of vaccination appointments against COVID-19 on 8 and 9 May, ages 31-34
, 07-05-2021
Rapid antigen testing for employees and the general population – Testing units 7 May 2021
, 07-05-2021
Answers to frequently asked questions on what changes as of 10 May 2021
, 06-05-2021
Opening of schools with physical presence – rapid test units for students
, 06-05-2021
Vaccination Portal opens for vaccination appointments for people of 35 and 36 years of age
, 06-05-2021
Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions to restart the economy and social activity
, 06-05-2021
Rapid antigen testing for employees and the general population – Testing units 6 May 2021
, 06-05-2021
Island-wide measures to combat the coronavirus pandemic – Effective from 10/05/2021
, 05-05-2021
The Pharmaceutical Services provide answers to frequently asked questions about the vaccines against COVID-19
, 05-05-2021
Rapid antigen testing for employees and the general population – Testing units 5 May 2021
, 05-05-2021
Changes in the process of arranging appointments through the COVID-19 Vaccination Portal as of 06/05/2021
, 04-05-2021
Rapid antigen testing for employees and the general population – Testing units 4 May 2021
, 04-05-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 03/05/2021
, 03-05-2021
Priority for vaccination against COVID-19 for the age group of 30-38 – Schedule for 4-7 May
, 03-05-2021
Rapid antigen testing for employees and the general population – Testing units 3 May 2021
, 01-05-2021
Rapid antigen testing for employees and the general population – Testing units 1 May 2021
, 01-05-2021
Rapid antigen testing for employees and the general population – Testing units 30 April 2021
, 30-04-2021
Rapid antigen testing for employees and the general population – Testing units 29 April 2021
, 29-04-2021
Revised list of laboratories conducting molecular tests for the new coronavirus (SARS-CoV-2) privately
, 28-04-2021
Revised list of clinical laboratories conducting rapid antigen tests
, 28-04-2021
Schedule for the arrangement of vaccination appointments against COVID-19 for April 29-30 and May 4th
, 28-04-2021
Rapid antigen testing for employees and the general population – Testing units 28 April 2021
, 28-04-2021
Vaccination against COVID-19 – Answers to frequently asked questions
, 27-04-2021
Period of administration of 2nd dose of AstraZeneca vaccine reduced to eight weeks
, 27-04-2021
Rapid antigen testing for employees and the general population – Testing units 27 April 2021
, 27-04-2021
National Vaccination Plan is in progress – Schedule for the period of 27-29 April
, 26-04-2021
Guidelines by the Minister of Transport, Communications and Works concerning Public and Private Transport
, 26-04-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 26/4/2021
, 26-04-2021
Answers to frequently asked questions on the measures to contain the COVID-19 pandemic (Effective between 26 April and 9 May)
, 26-04-2021
Rapid antigen testing for employees and the general population – Testing units 26 April 2021
, 26-04-2021
Vaccination coverage of the population continues – 20% of citizens have been vaccinated with the 1st dose of the vaccine
, 25-04-2021
The percentage of employees undergoing rapid antigen tests increases – Which categories of citizens are exempt from the obligation for testing
, 24-04-2021
Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions of the Council of Ministers concerning the pandemic
, 23-04-2021
Rapid antigen testing for employees and the general population – Testing units 24 April 2021
, 23-04-2021
Rapid antigen testing for employees and the general population – Testing units 23 April 2021
, 23-04-2021
Administration of the AstraZeneca vaccine by Personal Doctors to beneficiaries aged 30 and over
, 22-04-2021
Rapid antigen testing for employees and the general population – Testing units 22 April 2021
, 22-04-2021
Updated schedule for the period 22-25 April vaccination program against COVID-19
, 21-04-2021
Rapid antigen testing for employees and the general population – Testing units 21 April 2021
, 21-04-2021
COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
, 20-04-2021
Rapid antigen testing for employees and the general population – Testing units 20 April 2021
, 20-04-2021
Answers to frequently asked questions about coronavirus cases and close contacts
, 19-04-2021
Rapid antigen testing for employees and the general population – Testing units 19 April 2021
, 19-04-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 19/4/2021
, 19-04-2021
The implementation of the National Vaccination Plan continues – Appointments available for individuals aged 51-52
, 18-04-2021
Rapid antigen testing for employees and the general population – Testing units 18 April 2021
, 18-04-2021
Rapid antigen testing for employees and the general population – Testing units 17 April 2021
, 17-04-2021
Press conference on the next steps of the vaccination plan
, 16-04-2021
Rapid antigen testing for employees and the general population – Testing units 16 April 2021
, 16-04-2021
200,000 vaccinations administered in Cyprus until today – Priority to 53-54 age group for vaccination appointments on 16-17 April
, 15-04-2021
Rapid testing will be conducted nasally for the entire population
, 15-04-2021
Rapid antigen testing for employees and the general population – Testing units 15 April 2021
, 15-04-2021
Janssen vaccine will not be administered pending the completion of the investigation of thrombosis cases in the USA
, 14-04-2021
AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
, 14-04-2021
No self-isolation required for close contacts who have been vaccinated
, 14-04-2021
Rapid antigen testing for employees and the general population – Testing units 14 April 2021
, 14-04-2021
Requests for the COVID-19 home vaccination of bedridden individuals end on 16 April
, 13-04-2021
Schedule for the resumption of wedding and christening ceremonies
, 13-04-2021
Rapid antigen testing for employees and the general population – Testing units 13 April 2021
, 13-04-2021
Vaccination appointment programme for the period 13-17 April
, 12-04-2021
Rapid antigen testing for employees and the general population – Testing units 12 April 2021
, 12-04-2021
Rapid antigen testing for employees and the general population – Testing units 11 April 2021
, 11-04-2021
Vaccination portal opens on Sunday for individuals belonging to specific vulnerable groups
, 10-04-2021
Rapid antigen testing for employees and the general population – Testing units 10 April 2021
, 10-04-2021
15,000 appointments to be made available for the vaccination of individuals aged 57 and 58
, 09-04-2021
The British strain of the virus is dominant in the community of Cyprus - Detection of the English strain in 111 samples
, 09-04-2021
Rapid antigen testing for employees and the general population – Testing units 9 April 2021
, 09-04-2021
Access to the Vaccination Portal for the arrangement of appointments by individuals aged 59 and 60
, 09-04-2021
Change in the protocol for positive case tracing in schools
, 08-04-2021
Rapid antigen testing for employees and the general population – Testing units 8 April 2021
, 08-04-2021
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
, 07-04-2021
Rapid antigen testing for employees and the general population – Testing units 7 April 2021
, 07-04-2021
19,378 appointments to be made available for the vaccination of persons aged 61 and over
, 06-04-2021
Rapid antigen testing for employees and the general population – Testing units 6 April 2021
, 06-04-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 5/4/2021
, 05-04-2021
Rapid antigen testing for employees and the general population – Testing units 5 April 2021
, 05-04-2021
Vaccination Portal opens for individuals who use biological agents or other immunosuppressive medicines
, 04-04-2021
Rapid antigen testing for employees and the general population – Testing units 4 April 2021
, 04-04-2021
Rapid antigen testing for employees and the general population – Testing units 3 April 2021
, 03-04-2021
Rapid antigen testing for employees and the general population – Testing units 2 April 2021
, 02-04-2021
Rapid antigen testing for employees and the general population – Testing units 1 April 2021
, 01-04-2021
Passengers holding a vaccination certificate from the Republic of Cyprus will not have to self-isolate or undergo testing upon arrival in Cyprus
, 31-03-2021
AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
, 31-03-2021
Vaccination Portal to be made available for people aged 64 and over, on 1 April
, 31-03-2021
Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions of the Council of Ministers
, 31-03-2021
Vaccination Portal available until 31 March for patients with Diabetes Mellitus and Severe Obesity
, 31-03-2021
Operation of rapid antigen testing units in remote areas
, 31-03-2021
Rapid antigen tests for Gymnasium students
, 31-03-2021
Rapid antigen testing for employees and the general population – Testing units 31 March 2021
, 31-03-2021
Rapid antigen testing for employees and the general population – Testing units 30 March 2021
, 30-03-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 29/3/2021
, 29-03-2021
Rapid antigen testing for employees and the general population – Testing units 29 March 2021
, 29-03-2021
Over 19,000 vaccination appointments for individuals with Diabetes Mellitus and Severe Obesity
, 28-03-2021
Rapid antigen testing for employees and the general population – Testing units 28 March 2021
, 28-03-2021
Rapid antigen testing for employees and the general population – Testing units 27 March 2021
, 27-03-2021
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
, 26-03-2021
EMA issues advice on use of regdanvimab for treating COVID-19
, 26-03-2021
COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases
, 26-03-2021
Rapid antigen testing for employees and the general population – Testing units 26 March 2021
, 26-03-2021
Rapid antigen testing for employees and the general population – Testing units 25 March 2021
, 25-03-2021
Rapid antigen testing for employees and the general population – Testing units 24 March 2021
, 24-03-2021
Written statement by the Minister of Health, Mr Constantinos Ioannou
, 23-03-2021
Rapid antigen testing for employees and the general population – Testing units 23 March 2021
, 23-03-2021
Ministry of Health: Careful compliance with health measures to avoid deterioration of epidemiological picture
, 22-03-2021
A total of 310,000 individuals will have received at least the 1st dose of a vaccine by the beginning of May
, 22-03-2021
Cyprus ranks first in Europe in terms of testing and 5th in the EU in terms of vaccination coverage
, 22-03-2021
Rapid antigen testing for employees and the general population – Testing units 22 March 2021
, 22-03-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 22/3/2021
, 22-03-2021
Rescheduling of postponed appointments for vaccination with the AstraZeneca vaccine
, 21-03-2021
Rapid antigen testing for employees and the general population – Testing units 21 March 2021
, 21-03-2021
Rapid antigen testing for employees and the general population – Testing units 20 March 2021
, 20-03-2021
The Vaccination Portal will be made available for people aged 66 and over on 20 – 21 March
, 19-03-2021
Rapid antigen testing for employees and the general population – Testing units 19 March 2021
, 19-03-2021
AstraZeneca vaccinations to be carried out normally
, 18-03-2021
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
, 18-03-2021
Rapid antigen testing for employees and the general population – Testing units 18 March 2021
, 18-03-2021
Rapid antigen testing for employees and the general population – Testing units 17 March 2021
, 17-03-2021
Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues
, 16-03-2021
Rapid antigen testing for employees and the general population – Testing units 16 March 2021
, 16-03-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 15/3/2021
, 15-03-2021
Outdoor areas of catering establishments reopen in accordance with health protocol
, 15-03-2021
Postponement of vaccinations with the AstraZeneca vaccine until 18 March
, 15-03-2021
EMA’s Safety Committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update
, 15-03-2021
Rapid antigen testing for employees and the general population – Testing units 15 March 2021
, 15-03-2021
Clarifications on the measures that will apply on Green Monday
, 14-03-2021
Rapid antigen testing for employees and the general population – Testing units 14 March 2021
, 14-03-2021
Answers to frequently asked questions on what changes as of 15 March
, 13-03-2021
Rapid antigen testing for employees and the general population – Testing units 13 March 2021
, 13-03-2021
Statement by the Minister of Health, Mr Constantinos Ioannou, on the decisions of the Council of Ministers regarding the pandemic
, 12-03-2021
Rapid antigen testing for employees and the general population – Testing units 12 March 2021
, 12-03-2021
Revised list of clinical laboratories conducting rapid antigen tests that meet the specifications of the Ministry of Health
, 11-03-2021
EMA recommends COVID-19 Vaccine Janssen (Johnson&Johnson) for authorisation in the EU
, 11-03-2021
Presentation of CovTracer-EN contact tracing application by the Ministry of Health and the Deputy Ministry of Research
, 11-03-2021
High percentage of the British strain of the virus exists in Cyprus – Reduction of serious cases only through compliance with the measures
, 11-03-2021
Rapid antigen testing for employees and the general population – Testing units 11 March 2021
, 11-03-2021
COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria
, 11-03-2021
Rapid antigen testing for employees and the general population – Testing units 10 March 2021
, 10-03-2021
Rapid antigen testing for employees and the general population – Testing units 9 March 2021
, 09-03-2021
Vaccination Portal to be made available for people aged 67 and over – 22,808 vaccination appointments
, 08-03-2021
Rapid antigen testing for employees and the general population – Testing units 8 March 2021
, 08-03-2021
Rapid antigen testing for employees and the general population – Testing units 6 March 2021
, 06-03-2021
Rapid antigen testing for employees and the general population – Testing units 5 March 2021
, 05-03-2021
EMA starts rolling review of the Sputnik V COVID-19 vaccine
, 04-03-2021
Rapid antigen testing for employees and the general population – Testing units 4 March 2021
, 04-03-2021
Mobile testing units in schools for the convenience of school staff and students
, 03-03-2021
Rapid antigen testing for employees and the general population – Testing units 3 March 2021
, 03-03-2021
EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab)
, 02-03-2021
Vaccination Portal to be made available for people aged 69 and over – 17,496 vaccination appointments
, 02-03-2021
Rapid antigen testing for employees and the general population – Testing units 2 March 2021
, 02-03-2021
Cyprus, armed with the triptych “test-surveillance-vaccinations”, enters the new phase of the strategic lifting of measures
, 01-03-2021
Rapid antigen testing for employees and the general population – Testing units 1 March 2021
, 01-03-2021
Rapid antigen testing for employees and the general population – Testing units 28 February 2021
, 28-02-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 27/2/2021
, 27-02-2021
Rapid antigen testing for employees and the general population – Testing units 27 February 2021
, 27-02-2021
Rapid antigen testing for employees and the general population – Testing units 26 February 2021
, 26-02-2021
Answers to frequently asked questions on what changes as of 1 March
, 25-02-2021
Statement by the Minister of Health, Mr Constantinos Ioannou, during the announcement of the decisions of the Council of Ministers
, 25-02-2021
Rapid antigen testing for employees and the general population – Testing units 25 February 2021
, 25-02-2021
The objectives of the National Vaccination Plan are being achieved – More than 64,000 vaccines have been administered by the 23rd February
, 24-02-2021
Rapid antigen testing for employees and the general population – Testing units 24 February 2021
, 24-02-2021
Rapid antigen testing for employees and the general population – Testing units 23 February 2021
, 23-02-2021
As of 23 February, 16,904 vaccination appointments will be made available for people aged 71 and over
, 22-02-2021
Rapid antigen testing for employees and the general population – Testing units 22 February 2021
, 22-02-2021
Rapid antigen testing for employees and the general population – Testing units 21 February 2021
, 21-02-2021
Rapid antigen testing for employees and the general population – Testing units 20 February 2021
, 20-02-2021
COVID-19 Vaccination of specific categories of the population based on serious illness risk factors
, 19-02-2021
Rapid antigen testing for employees and the general population – Testing units 19 February 2021
, 19-02-2021
The Council of Ministers has approved the resumption of flights and re-opening of airports with additional security measures
, 18-02-2021
Rapid antigen testing for employees and the general population – Testing units 18 February 2021
, 18-02-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 17/2/2021
, 17-02-2021
Rapid antigen testing for employees and the general population – Testing units 17 February 2021
, 17-02-2021
National Vaccination Plan for COVID-19: 9.096 appointments for persons aged 74 and over
, 16-02-2021
Rapid antigen testing for employees and the general population – Testing units 16 February 2021
, 16-02-2021
Over 402,000 rapid tests in the 1st half of February – Continuous surveillance of the epidemiological picture is the main aim
, 16-02-2021
Rapid antigen testing for employees and the general population – Testing units 15 February 2021
, 15-02-2021
Mandatory weekly screening with rapid antigen testing for the self-employed and domestic workers
, 14-02-2021
Rapid antigen testing for employees and the general population – Testing units 14 February 2021
, 13-02-2021
Rapid antigen testing for employees and the general population – Testing units 13 February 2021
, 12-02-2021
Statement by the Minister of Health, Mr Constantinos Ioannou, at the press conference on the National Vaccination Plan for COVID-19
, 12-02-2021
EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV)
, 12-02-2021
Rapid antigen testing for employees and the general population – Testing units 12 February 2021
, 12-02-2021
9,264 Vaccination appointments made available for people over the age of 76
, 11-02-2021
Rapid antigen testing for employees and the general population – Testing units 11 February 2021
, 11-02-2021
Second phase of strategic gradual de-escalation of restrictive measures extended until 28 February
, 10-02-2021
Clarifications regarding the administration of AstraZeneca vaccine to specific age groups
, 10-02-2021
Rapid antigen testing for employees and the general population – Testing units 10 February 2021
, 10-02-2021
Third phase of the National Vaccination Plan for COVID-19 begins with appointments made available for people over the age of 79
, 09-02-2021
Rapid antigen testing for employees and the general population – Testing units, 9 February 2021
, 09-02-2021
Rapid antigen testing for employees and the general population is in progress at 59 units (Testing Units – 8 February 2021)
, 08-02-2021
Rapid antigen testing for employees and the general population– Testing units
, 07-02-2021
Rapid antigen testing for employees and the general population is in progress – Testing units
, 06-02-2021
Cyprus ranks second among EU countries in terms of coronavirus testing
, 05-02-2021
Rapid antigen testing for employees and the general population is in progress – Testing units
, 05-02-2021
List of clinical laboratories conducting rapid COVID-19 antigen test for which no molecular confirmation is required
, 05-02-2021
Rapid antigen testing for employees and the general population is in progress - Testing units
, 04-02-2021
Revised list of private laboratories for the new coronavirus (SARS-CoV-2) molecular test
, 04-02-2021
EMA starts rolling review of Novavax’s COVID-19 vaccine (NVX-CoV2373)
, 04-02-2021
Decisions of the Council of Ministers regarding the reopening of the sports sector
, 03-02-2021
Self-isolation for 72 hours and laboratory testing 72 hours after arrival for all passengers arriving in the Republic of Cyprus
, 03-02-2021
Cabinet adopts decision for the reopening of indoor theatres and cinemas as of 8 February
, 03-02-2021
Testing for employees returning to work on 8 February is in progress
, 03-02-2021
Vaccination Portal to be made available to citizens over the age of 83
, 02-02-2021
Testing for employees returning to work on 8 February, begins
, 01-02-2021
Vaccination appointments for citizens over the age of 84 – 7,790 vaccine doses administered during the week of 23-29 January
, 30-01-2021
Rapid tests for employees and the general population continue – Information about testing units on 30 January 2021
, 29-01-2021
EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU
, 29-01-2021
Answer to frequently-asked questions on COVID-19 Vaccine AstraZeneca
, 29-01-2021
*Revised* - Answers to frequently asked questions on what changes as of 1 February, in the framework of the strategic lifting of measures to contain the COVID-19 pandemic
, 29-01-2021
COVID-19 vaccine safety update for Comirnaty
, 29-01-2021
First COVID-19 vaccine safety update published
, 29-01-2021
Clarification of Comirnaty dosage interval
, 29-01-2021
Vaccination Portal to be made available to citizens over the age of 86 as of 29 January – New appointments as of 1st February
, 28-01-2021
Answers to frequently asked questions on what changes as of 1 February, in the framework of the strategic lifting of measures to contain the COVID-19 pandemic
, 27-01-2021
The measures relating to flights and airports shall be extended until 1st March 2021
, 27-01-2021
Statement by the Minister of Health, Mr Constantinos Ioannou, during the announcement of the 1st phase of the strategic lifting of measures
, 27-01-2021
Change of Contact Information for the Call Centre of the electronic platform "CyprusFlightPass"
, 26-01-2021
Vaccination Portal to be made available to citizens over the age of 88 as of 27 January
, 26-01-2021
Cost of the laboratory test (RT-PCR) for Covid-19 at Larnaka and Pafos airports
, 21-01-2021
Revised procedure for arranging vaccination appointments for COVID-19
, 19-01-2021
Epidemiological risk assessment of countries concerning COVID-19, dated 16/1/2021
, 16-01-2021
(Revised**) Answers to frequently asked questions on measures to contain the COVID-19 pandemic
, 15-01-2021
(Revised*) Answers to frequently asked questions on measures to contain the COVID-19 pandemic
, 12-01-2021
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
, 12-01-2021
Press release by the Deputy Ministry of Research, Innovation and Digital Policy on citizens' movements by exception
, 09-01-2021
Answers to frequently asked questions on measures to contain the COVID-19 pandemic
, 08-01-2021
Statement by Minister of Health Mr Constantinos Ioannou regarding the announcement of the new measures against the pandemic
, 08-01-2021
EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU
, 06-01-2021
Answers to frequently asked questions on COVID-19 Vaccine Moderna
, 06-01-2021
Update on rolling review of AstraZeneca’s COVID-19 vaccine
, 31-12-2020
Presence of persons in houses other than permanent residents is prohibited – Remote working for public/wider public sector
, 29-12-2020
Updated list of categories of citizens with risk factors for serious illness by COVID-19
, 29-12-2020
Antigen detection tests (rapid tests) do not need to be confirmed with a PCR test
, 28-12-2020